The activist shareholder helped the UK insurer deliver cost cuts and release capital. Axa CEO Thomas Buberl has a similar ...

Novo Nordisk muscled in on Pfizer’s bid for US drugmaker Metsera with a $9 bln offer. The $226 bln Danish group is paying a ...

Shares of the $1.5 bln tinned fish maker Princes slipped after it priced at the bottom of the range. It adds to a dismal year ...

Persistent budget deficits have fuelled fears the US will monetise public debt of 114% of GDP. A simple hedge is to switch to ...

Apollo, KKR and others turbo-charged their credit divisions by selling annuities. It drove a surge in sales of the retirement ...

The Finnish group gained over 20%, or $7 bln, after the chip giant unveiled a $1 bln investment. But the partnership is not ...

Microsoft, Alphabet and Meta spent another $60 bln combined in the quest to conquer machine learning. The Windows maker can ...

US and European lenders from Deutsche to Santander and JPMorgan are worth some 50% more, as a multiple of book value, than ...

The Russell 2000, an index tracking sub-$5 bln firms, is up 11% this year. Yet these diminutive strivers’ hopes of closing a valuation gap to larger rivals face profitability and growth woes. With ...

The country’s new leader wants to revive former PM Shinzo Abe’s reflationary agenda when prices are already rising at 3% a ...

The 75 bln euro French bank's shares slipped despite respectable results, widening the discount it is trading at compared to ...

Japan is backing a provisional $80 bln plan with Brookfield, the US government and others to build power plants. It’s the ...